Global Drug-Eluting Balloons Sales Market Report 2018 by Manufacturer, Region, Type and Application

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Drug-Eluting Balloons Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Semi-Compliant Balloons Market Performance (Volume)
  • 2.1.2 Non-Compliant Balloons Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Semi-Compliant Balloons Market Performance (Value)
  • 2.1.2 Non-Compliant Balloons Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Treatment of In-stent Restenosis (ISR) Market Performance (Volume)
  • 3.1.2 Treatment of Small Vessel Disease (SVD) Market Performance (Volume)
  • 3.1.3 Treatment of Bifurcation Stenoses Market Performance (Volume)
  • 3.1.4 Treatment of Primary Coronary Artery Disease Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Boston Scientific
  • 4.1.1 Boston Scientific Profiles
  • 4.1.2 Boston Scientific Product Information
  • 4.1.3 Boston Scientific Drug-Eluting Balloons Business Performance
  • 4.1.4 Boston Scientific Drug-Eluting Balloons Business Development and Market Status
• 4.2 Medtronic
  • 4.2.1 Medtronic Profiles
  • 4.2.2 Medtronic Product Information
  • 4.2.3 Medtronic Drug-Eluting Balloons Business Performance
  • 4.2.4 Medtronic Drug-Eluting Balloons Business Development and Market Status
• 4.3 Cook Medical
  • 4.3.1 Cook Medical Profiles
  • 4.3.2 Cook Medical Product Information
  • 4.3.3 Cook Medical Drug-Eluting Balloons Business Performance
  • 4.3.4 Cook Medical Drug-Eluting Balloons Business Development and Market Status
• 4.4 C.R. Bard
  • 4.4.1 C.R. Bard Profiles
  • 4.4.2 C.R. Bard Product Information
  • 4.4.3 C.R. Bard Drug-Eluting Balloons Business Performance
  • 4.4.4 C.R. Bard Drug-Eluting Balloons Business Development and Market Status
• 4.5 B. Braun
  • 4.5.1 B. Braun Profiles
  • 4.5.2 B. Braun Product Information
  • 4.5.3 B. Braun Drug-Eluting Balloons Business Performance
  • 4.5.4 B. Braun Drug-Eluting Balloons Business Development and Market Status
• 4.6 Eurocor GmbH
  • 4.6.1 Eurocor GmbH Profiles
  • 4.6.2 Eurocor GmbH Product Information
  • 4.6.3 Eurocor GmbH Drug-Eluting Balloons Business Performance
  • 4.6.4 Eurocor GmbH Drug-Eluting Balloons Business Development and Market Status
• 4.7 Blue Medical
  • 4.7.1 Blue Medical Profiles
  • 4.7.2 Blue Medical Product Information
  • 4.7.3 Blue Medical Drug-Eluting Balloons Business Performance
  • 4.7.4 Blue Medical Drug-Eluting Balloons Business Development and Market Status
• 4.8 Bayer
  • 4.8.1 Bayer Profiles
  • 4.8.2 Bayer Product Information
  • 4.8.3 Bayer Drug-Eluting Balloons Business Performance
  • 4.8.4 Bayer Drug-Eluting Balloons Business Development and Market Status
• 4.9 Aachen Resonance
  • 4.9.1 Aachen Resonance Profiles
  • 4.9.2 Aachen Resonance Product Information
  • 4.9.3 Aachen Resonance Drug-Eluting Balloons Business Performance
  • 4.9.4 Aachen Resonance Drug-Eluting Balloons Business Development and Market Status
• 4.10 Acrostak
  • 4.10.1 Acrostak Profiles
  • 4.10.2 Acrostak Product Information
  • 4.10.3 Acrostak Drug-Eluting Balloons Business Performance
  • 4.10.4 Acrostak Drug-Eluting Balloons Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Global Drug-Eluting Balloons Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Drug-Eluting Balloons Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Drug-Eluting Balloons Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Drug-Eluting Balloons Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Drug-Eluting Balloons Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Drug-Eluting Balloons Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Drug-Eluting Balloons Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Drug-Eluting Balloons Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 USA Market Performance for Manufacturers
  • 6.2.1 USA Drug-Eluting Balloons Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 USA Drug-Eluting Balloons Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 USA Drug-Eluting Balloons Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 USA Drug-Eluting Balloons Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 Europe Market Performance for Manufacturers
  • 6.3.1 Europe Drug-Eluting Balloons Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 Europe Drug-Eluting Balloons Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 Europe Drug-Eluting Balloons Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 Europe Drug-Eluting Balloons Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Japan Market Performance for Manufacturers
  • 6.4.1 Japan Drug-Eluting Balloons Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Japan Drug-Eluting Balloons Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Japan Drug-Eluting Balloons Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Japan Drug-Eluting Balloons Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Korea Market Performance for Manufacturers
  • 6.5.1 Korea Drug-Eluting Balloons Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Korea Drug-Eluting Balloons Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Korea Drug-Eluting Balloons Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Korea Drug-Eluting Balloons Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 India Market Performance for Manufacturers
  • 6.6.1 India Drug-Eluting Balloons Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 India Drug-Eluting Balloons Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 India Drug-Eluting Balloons Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 India Drug-Eluting Balloons Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Southeast Asia Market Performance for Manufacturers
  • 6.7.1 Southeast Asia Drug-Eluting Balloons Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Southeast Asia Drug-Eluting Balloons Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Southeast Asia Drug-Eluting Balloons Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Southeast Asia Drug-Eluting Balloons Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 South America Market Performance for Manufacturers
  • 6.8.1 South America Drug-Eluting Balloons Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 South America Drug-Eluting Balloons Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 South America Drug-Eluting Balloons Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 South America Drug-Eluting Balloons Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Global Drug-Eluting Balloons Market Performance (Sales Point)

• 7.1 Global Drug-Eluting Balloons Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Global Drug-Eluting Balloons Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Global Drug-Eluting Balloons Price (USD/Unit) by Regions 2013-2018
• 7.4 Global Drug-Eluting Balloons Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Global Drug-Eluting Balloons Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Drug-Eluting Balloons Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 USA Drug-Eluting Balloons Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 Europe Drug-Eluting Balloons Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Japan Drug-Eluting Balloons Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Korea Drug-Eluting Balloons Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 India Drug-Eluting Balloons Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Southeast Asia Drug-Eluting Balloons Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Southeast Asia Drug-Eluting Balloons Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Treatment of In-stent Restenosis (ISR) Industry
• 11.2 Treatment of Small Vessel Disease (SVD) Industry
• 11.3 Treatment of Bifurcation Stenoses Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Global Drug-Eluting Balloons Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Global Drug-Eluting Balloons Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 China Drug-Eluting Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 USA Drug-Eluting Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 Europe Drug-Eluting Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Japan Drug-Eluting Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Korea Drug-Eluting Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 India Drug-Eluting Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Southeast Asia Drug-Eluting Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 South America Drug-Eluting Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Semi-Compliant Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Non-Compliant Balloons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Treatment of In-stent Restenosis (ISR) Sales and and Growth Rate 2019-2024
  • 12.4.3 Treatment of Small Vessel Disease (SVD) Sales and and Growth Rate 2019-2024
  • 12.4.4 Treatment of Bifurcation Stenoses Sales and and Growth Rate 2019-2024
  • 12.4.5 Treatment of Primary Coronary Artery Disease Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Global Drug-Eluting Balloons Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Global Drug-Eluting Balloons Gross Profit Trend 2019-2024

13 Conclusion